Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention.
about
Interleukin-22 Signaling in the Regulation of Intestinal Health and DiseaseThe Newly Identified T Helper 22 Cells Lodge in LeukemiaRole of interleukin-22 in liver diseases.Role of interleukin-22 in inflammatory bowel diseaseIL-22 is related to development of human colon cancer by activation of STAT3.Key mediators in the immunopathogenesis of allergic asthmaIncreased Tc22 and Treg/CD8 ratio contribute to aggressive growth of transplant associated squamous cell carcinoma.Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders.The alteration and clinical significance of Th22/Th17/Th1 cells in patients with chronic myeloid leukemiaCell-mediated immune responses to respiratory syncytial virus infection: magnitude, kinetics, and correlates with morbidity and ageSerum levels of selected Th17 and Th22 cytokines in psoriatic patients.T helper cytokines in dry eye diseaseEffects of dietary glutamine on the homeostasis of CD4+ T cells in mice with dextran sulfate sodium-induced acute colitis.Elevated peripheral frequencies of Th22 cells: a novel potent participant in obesity and type 2 diabetesElevated Th22 cells correlated with Th17 cells in peripheral blood of patients with acute myeloid leukemia.Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis.Th22 cells are associated with hepatocellular carcinoma development and progression.Emerging role of interleukin-22 in autoimmune diseasesTh22 and related cytokines in inflammatory and autoimmune diseases.Functions of the aryl hydrocarbon receptor in the skin.Targeting interleukin-22 in psoriasis.Advances in understanding the pathogenesis of autoimmune disorders: focus on chemokines and lymphocyte trafficking.Immunological milieu in mycosis fungoides and Sézary syndrome.Helper T-cell differentiation in graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.Activation of human T cells by CD1 and self-lipids.Biological and pathological activities of interleukin-22.Role of IL-22- and TNF-α-producing Th22 cells in uveitis patients with Behcet's diseaseAssociation of genetic polymorphisms of interleukins with gastric cancer and precancerous gastric lesions in a high-risk Chinese population.DNAX-activating protein 10 (DAP10) membrane adaptor associates with receptor for advanced glycation end products (RAGE) and modulates the RAGE-triggered signaling pathway in human keratinocytesDownregulation of RUNX3 moderates the frequency of Th17 and Th22 cells in patients with psoriasisOMIP-017: human CD4(+) helper T-cell subsets including follicular helper cells.A High Frequency of Peripheral Blood IL-22(+) CD4(+) T Cells in Patients With New Onset Type 2 Diabetes Mellitus.Th1, Th2, Th17 and regulatory T cell pattern in psoriatic patients: modulation of cytokines and gene targets induced by etanercept treatment and correlation with clinical response.Increased Th22 cells are independently associated with Th17 cells in type 1 diabetes.Th9 and Th22 immune response in young patients with type 1 diabetes.Aberrant NLRP3 inflammasome associated with aryl hydrocarbon receptor potentially contributes to the imbalance of T-helper cells in patients with acute myeloid leukemia.IL-22+CD4+ T-cells in patients with active systemic lupus erythematosus.Unexplained infertility patients have increased serum IL-2, IL-4, IL-6, IL-8, IL-21, TNFα, IFNγ and increased Tfh/CD4 T cell ratio: increased Tfh and IL-21 strongly correlate with presence of autoantibodies.Th22, but not Th17 might be a good index to predict the tissue involvement of systemic lupus erythematosus.Recruitment and significance of Th22 cells and Th17 cells in malignant ascites
P2860
Q26770224-EEA5E129-BBA0-44FC-B6ED-5CE2C912BC31Q26799454-93819512-1F0A-4BB5-BE6E-A3A952EB2E19Q33729412-24955F5C-F222-4764-BEDD-A5AFECD08DF8Q34456769-B00A19ED-8BF7-4FD6-915D-ED1CFFB5E00CQ34573878-5E4753DD-E823-4D35-A149-3ED0DCD6AE99Q34621642-945C3487-5EEF-4781-9088-D13ED0177AD9Q34717034-07B5A86D-F314-4CB7-A760-D0C84AC131F4Q35068792-F70ECC03-C9E7-4677-BEE8-347A3E9D4FAFQ35592370-2B9A07DB-0D65-4573-ACA1-E70A7FF06F6FQ36977881-A42E4F55-AB55-4A4E-9609-26A91E1CB8D2Q37322356-5AE2CC51-5E5A-4E6B-A3D0-0D14241173C4Q37374838-B30A95C0-73BC-4D73-A760-8D80AF4B09CFQ37458560-FE0ABBDF-19C9-49F1-91BD-C3D745783BB5Q37490734-F7EDB8CF-A75F-4C5C-8DD2-5DAA9C0B2464Q37645126-DD5DC00E-0507-4E74-9AFD-A8BA823DAD3DQ37709681-7004A82F-2F3A-4F38-8F82-00B4AB1666D9Q37725429-F74AFF6F-82D4-420A-83FD-934946445759Q37730867-146F2295-95C3-488F-879D-66EBEA3F2EE1Q38068964-C997F80B-1771-4CD4-8360-C4E9C791D3B8Q38129298-1932E91A-6A76-46A0-9999-5E283E505C8BQ38131660-20C2F723-B53D-4E54-9428-2CE96533B393Q38155907-D31A0ED6-3DC7-4852-811D-B8F589BAB3FEQ38179489-21D52823-E68D-4C9C-8618-1716F2A03AF3Q38202009-62184F66-6489-456E-AEE0-063FE123D118Q38568857-B895C21C-33D4-4917-B24F-16A7387D4C02Q38753752-514F2F02-F227-4398-A7FF-610D0ACCA15DQ39158352-6356644D-348C-4A86-AEA5-CE819E21CDE6Q41006391-7364FB31-CBC9-413B-9BDF-D59A83306414Q42266144-E580837B-9890-457F-B532-F54A8BDB5E40Q42568263-2811602F-0375-45B8-82C9-9A0FDA4C096FQ43171954-29E91A56-4378-472C-91D0-E37B7D98BD96Q45221291-DBFE009F-9BCB-48A8-AED8-4DBCBA379C02Q45917463-29D94306-9F63-48D7-A26B-A6B6C8D5C042Q47824146-DE50E287-B7ED-4B28-9CFA-0DDB46B03D17Q48090733-36B12692-A66C-4136-8F6C-89474436C00FQ49437275-5C59EF2C-12D3-400D-95EB-46B80614D91DQ51074868-7CAA8058-8FE7-4ACE-8A16-F1E9BB92C41BQ51512089-F32B3743-E2F9-44E1-8F4B-49C0022AC123Q53119004-CED85568-D632-418D-B920-6BF36D1A5FE5Q58772549-34B8693E-CFAA-4D05-B979-0E9474E39A95
P2860
Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention.
@en
Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention.
@nl
type
label
Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention.
@en
Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention.
@nl
prefLabel
Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention.
@en
Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention.
@nl
P2860
P1476
Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention.
@en
P2093
Dong-Qing Ye
Ning Zhang
P2860
P2888
P356
10.1007/S11010-011-0772-Y
P50
P577
2011-03-08T00:00:00Z